This review presents some basic concepts in using drugs with narrow therapeutic index, some properties of calcineurin inhibitors, bioequivalence requirements for safe and effective clinical use, and pointers to keep in mind when using generic drugs of calcineurin inhibitors for interchangeability and substitution in organ transplantation.